Abstract
The results are presented of a search for hybrid Β-adrenergic blocking agents (combining Β-adrenergic blocking activity with α-adrenergic blocking, vasodilating properties, and also the ability to inhibit the angiotensin-converting enzyme) and Β-adrenergic blocking agents with a prolonged effect among the derivatives of 5-phenoxymethyl-1,2,4-oxadiazole and 4-(2-hydroxy-3-alkylaminopropoxy)indole. One of the studied substances (proxodolol) was introduced into medical practice as a highly efficacious antihypertensive. antianginal, and antiglaucoma drug.
Similar content being viewed by others
References
C. Dahlof,Circulation. 84 (Suppl. 6), VI-108 (1991).
C. T. Dollery,J. Cardiovasc. Pharmacol..11 (Suppl. 2). S1 - S4 (1988).
W. Haverkamp, G. Hindriks, and H. Gulker,J. Cardiovasc. Pharmacol..16 (Suppl. 5). S29- S32 (1990).
J. W. Upward, D. G. Waller, and C. T. George.Pharmacol. Ther.,37, 81 - 109 (1988).
L. Hannson,Am. J. Cardiol.,67, 43 - 46 (1991).
S. Levy,J. Cardiovasc. Pharmacol.,16 (Suppl. 6), S50 - S54 (1990).
B. N. Singh,Am. J. Cardiol.,66, 9C - 19C (1990).
G. Olsson and L. Ryden,Circulation,84 (Suppl. 6). VI - 33 (1984).
B. M. Psaty, T. D. Koepsell, E. H. Wagner, et al.,Am. J. Cardiol.,66, 14 - 24 (1990).
E. J. Eichhorn,Am. J. Med.,92, 527 - 538 (1992).
B. E. Straner,J. Cardiovasc. Pharmacol.,16 (Suppl. 5). S129 - S132 (1990).
S. D. Yuzhakov and M. D. Mashkovskii,Khim.-Farm. Zh.,20(8), 918 - 929 (1986).
B. N. C. Prichard,Drugs,28 (Suppl. 2), S1 - S8 (1984).
G. Allan, D. Cambridge. G. W. Hardy, et al.,J. Hypertens.,4 (Suppl. 6). 5131 - 5133 (1986).
E. Bouley, J. M. Teulon, Cazes, et al.,J. Med. Chem.,29, 100 - 104 (1986).
V. Cecchetti,J. Med. Chem.,36, 157 - 161 (1993).
V. Cecchetti, F. Schiofella, O. Tobarrini, et al.,Eur. J. Med. Chem.,26, 381 - 386 (1991).
R. Liss, T. K. Morgan, A. J. Marisca, et al.,J. Med. Chem.,33. 2883 - 2891 (1990).
T. K. Morgan, R. Liss, W. C. Lumma, et al.,J. Med. Chem.,33. 1091 - 1097 (1990).
J. B. Phillips, T. K. Morgan, W. C. Lumma, et al.,J. Med. Chem.,35, 743 - 750 (1992).
K. Shibasaki, W. Uchida, J. Matsuda, et al.,Arch. Int. Pharmacodyn.,313, 140 - 150 (1991).
S. D. Sokolov, S. M. Vinogradova, M. V. Berg, et al.,Éksp. Klin. Farmakol., No. 2, 48 - 55 (1984).
S. D. Sokolov, S. M. Vinogradova, M. V. Berg, et al.,Éksp. Klin. Farmakol., No. 2, (1994).
M. D. Mashkovskii and S. D. Yuzhakov,Éksp. Klin. Farmakol., No. 3, 27 - 30 (1994).
S. D. Yuzhakov and M. D. Mashkovskii.Khim.-Farm. Zh..28(6), 3 - 5 (1994).
S. D. Yuzhakov, O. V. Dolgun, E. V. Dorodnikova. et al.Éksp Klin. Farmacol., No. 3, 30 - 33 (1994).
R. G. Glushkov, M. D. Mashkovskii, G. K. Skryabin, et al.,Khim.-Farm. Zh.,26(6), 18 - 24 (1992).
R. G. Glushkov, M. D. Mashkovskii, N. N. Suvorov, et al.,Khim.-Farm. Zh.,27(8), 8- 13 (1993).
M. D. Mashkovskii, L. Kh. Vinograd, S. D. Yuzhakov. et al.,Khim.-Farm. Zh.,27(10), 16 - 20 (1993).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yuzhakov, S.V. Urgent problems in the search for and creation of β-adrenergic blocking agents. Pharm Chem J 29, 75–77 (1995). https://doi.org/10.1007/BF02226512
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02226512